Enzon’s Acquisition of Abelcet
By Business Review Editor
Pharma Deals Review: Vol 2002 Issue 30 (Table of Contents)
Published: 2 Nov-2002
DOI: 10.3833/pdr.v2002.i30.980 ISSN: 1756-7874
Section: General
Abstract
Last month Enzon planned to acquire the North American and Japanese rights to the antifungal, Abelcet, from Elan with a total payment of US$370 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018